Particle Sciences focuses on BCS II/III/IV molecules, biologics and potent compounds through different technologies such as emulsions, gels, micro and nano-particulates, drug/device combination products, solid solutions and others.
Particle Sciences formulation services director Garry Gwozdz said the company is seeing an increasing demand for thin film-based products, particularly with respect to transdermal drug-eluting patch products, and rapidly-dissolving strips.
"While we have been working in this area for some time, the acquisition of semi-automated coating equipment will allow us to screen more formulation approaches, and get our clients into the clinic faster with a commercially representative film-based product," Gwozdz added.
"Particle Sciences already had cGMP hot-melt film extrusion capability and now with the addition of coating and drying capabilities for liquid-based formulations, our clients have access to a complete array of viable and scalable film-manufacturing technologies."